Skip to content
Review

Targeting lncRNA-regulated macrophage polarization: a novel therapeutic strategy for pancreatic ductal adenocarcinoma

Sep 2026 · Journal of physiology and biochemistry · Vol 82 · 0 citations · 145 references
Medicine

TL;DR

Key lncRNAs involved in TAM polarization in PDAC are summarized, highlighting their roles in inducing the M2 phenotype and promoting PDAC progression through epigenetic modifications, ceRNA networks, and signal transduction pathways.

View source

Similar papers

Sep 2026

Abstract B014: Leveraging dynamic epigenetic landscapes to decode tumor-associated macrophages in pancreatic ductal adenocarcinoma

Leveraging the MITF-dependent gene signature activated in macrophages, this work sought to address how MITF-associated enhancers are mechanistically influencing PDAC TAM functions as the tumor becomes more advanced and develops chemoresistance.

Debbie K. Ledezma, K. Gulay, Hervé Tiriac et al. · 0 citations
Sep 2026

The post-transcriptional regulator HuR promotes immune evasion in pancreatic ductal adenocarcinoma.

Overall, it is found that the post-transcriptional regulator HuR facilitates immune evasion in PDAC by constraining T-cell function, identifying HuR blockade as a promising therapeutic strategy in combination with immunotherapies.

Yi-Fei Guo, Jennifer M. Finan, Alexandra Q. Bartlett et al. · 0 citations
Review Open access Aug 2026

Tumor‐Associated Macrophages in the Chemoresistant Microenvironment of Gastric Cancer: Key Mechanisms and Intercellular Crosstalk

Current evidence on TAM‐driven chemoresistance in GC is synthesized, highlighting the molecular interplay between TAMs, tumor cells, and stromal components and underscores the potential of TAM‐centric therapies to overcome resistance and improve clinical outcomes.

S. Abdul-Rahman, Abdulkareem Shareef, S. Jyothi et al. · 0 citations
Sep 2026

Abstract B124: Targeting the tumor microenvironment: A novel therapeutic strategy for pancreatic ductal adenocarcinoma

Therapeutic N-glycan modulation is highlighted as a promising tumor microenvironment–targeted strategy for PDAC treatment by disrupting tumor–stroma communication and remodeling the tumor microenvironment by disrupting tumor–stroma communication and remodeling the tumor microenvironment.

Hui-Lan Chang, Chin-Chun Chang, Gita Riswana Nawung Rida et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.